YANNA XIONG: Open Payments
NPI 1730896788 · MONTEREY PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 30 payments from 11 companies in 2025. Trend: 2023 $323 · 2024 $770 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $193 |
| Madrigal Pharmaceuticals | 8 | $178 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Novo Nordisk Inc | 2 | $64 |
| QOL Medical, LLC | 2 | $60 |
| ABBVIE INC. | 2 | $58 |
| Gilead Sciences, Inc. | 2 | $57 |
| Phathom Pharmaceuticals, Inc. | 1 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
Products named: IBSRELA, REZDIFFRA, Wegovy, Sucraid, ZENPEP, VOQUEZNA, CREON, OCALIVA.
Industry payments across CA — which companies pay providers there.
